SCHEMBL25147207

SCHEMBL25147207

CC1(C)c2cc3c4ccccc4n(-c4ccccc4)c3cc2-c2cc3c(cc21)c1ccccc1n3-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ ATM Q13315 1/20 0.56
▸ MAPK8 P45983 2/20 0.37
▸ PGR P06401 3/20 0.36
▸ KMT2A Q03164 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ HPGD P15428 2/20 0.34
▸ IL1R1 P14778 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12594472 0.98 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL18351613 0.96 KDM4E (0.51) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL10014046 0.94 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL802130 0.94 KDM4E (0.56) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL18381859 0.93 KDM4E (0.49) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL12116350 0.93 KDM4E (0.49) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL17988889 0.93 KDM4E (0.49) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL18351605 0.93 KDM4E (0.51) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL14822438 0.92 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK8PGR
SCHEMBL801946 0.92 KDM4E (0.55) KDM4EL3MBTL1ATMMAPK8PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228523-A1 Metal complexes UDC IRELAND LTD (IE) 2024-07-11 — — US disclosed
WO-2024133211-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2024-06-27 — — WO disclosed
WO-2023099430-A1 TRIPHENYLENE-TRIAZINE-DIBENZOFURAN/DIBENZOTHIOPHENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-08 — — WO disclosed
WO-2023078812-A1 BENZOFURO[3,2-D]PYRIMIDINO-2,4-DICARBONITRIL DERIVATIVES AND SIMILAR COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2023-05-11 — — WO disclosed
WO-2023061998-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-04-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228523-A1 Metal complexes MCU, IMMT, SOD1 KDM4E 4540/4885L3MBTL1 3190/4885ATM 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback